Brian Dennis Lichty (Brian D Lichty)

Years Active: 2018-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, Matthew S Miller, Brian Dennis Lichty, Zhou Xing
Immunological considerations for COVID-19 vaccine strategies. Nature reviews. Immunology 20 (10) (2020)
Marie-Claude Bourgeois-Daigneault, Dominic Guy Roy, Amelia Sadie Aitken, Nader El Sayes, Nikolas Tim Martin, Oliver Varette, Theresa Falls, Lauren Elizabeth St-Germain, Adrian Pelin, Brian Dennis Lichty, David Francis Stojdl, Guy Ungerechts, Jean-Simon Diallo, John Cameron Bell
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. Science translational medicine 10 (422) (2019)
Jonathan G Pol, Sergio A Acuna, Beta Yadollahi, Nan Tang, Kyle B Stephenson, Matthew J Atherton, David Hanwell, Alexander El-Warrak, Alyssa Goldstein, Badru Moloo, Patricia V Turner, Roberto Lopez, Sandra LaFrance, Carole Evelegh, Galina Denisova, Robin Parsons, Jamie Millar, Gautier Stoll, Chantal G Martin, Julia Pomoransky, Caroline J Breitbach, Jonathan L Bramson, John C Bell, Yonghong Wan, David F Stojdl, Brian Dennis Lichty, J Andrea McCart
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials. Oncoimmunology 8 (1) (2018)

Brian Dennis Lichty.css-eqlu8i{font-size:small;padding-left:4px;} (Brian D Lichty)